APHIS HomeAbout APHISNewsroomCareer OpportunitiesHelpContact Us
Decrease Font Size Increase Font Size
Search
 
USDA in Facebook APHIS in Twitter APHIS in Youtube APHIS Stakeholder Registry APHIS in Pictures APHIS in Blog APHIS RSS News Feeds

Browse by Subject
Animal Health
Animal Welfare
Biotechnology
Emergency Preparedness and Response
Import and Export
International Services
Permits
Plant Health
Regulations and Assessments
APHIS User Fees
Wildlife Control and Management
Regulations and Assessments

Wildlife Damage Management

NOTICE OF AVAILABILITY:  The United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services (WS) has issued a Decision and Finding of No Significant Impact (FONSI) for a supplement to an Environmental Assessment (EA) entitled “Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector, in New Hampshire, New York, Ohio, Vermont, and West Virginia”.  The EA evaluated potential environmental impacts to the quality of the human environment from the implementation of a field trial to determine the safety and immunogenicity of the human adenovirus type 5 – rabies glycoprotein (AdRG1.3) (the trade name for this product is ONRAB; Artemis Technologies Inc., Guelph, Ontario, Canada) rabies vaccine in the above mentioned states.  A Decision/FONSI was issued for the EA on August 13, 2012.  The supplement to the EA was prepared to examine the potential environmental impacts of WS’ program as is relates to expanding the geographic range of the field trial zone in New York.  Additionally, the supplement to the EA presents new information that has become available from public comments, research findings, and data gathering since the issuance of the Decision/FONSI.  Based on the analyses contained in the EA, the 2012 Decision/FONSI, the supplement, and review of public comments, it was concluded that continued implementation of the proposed action, as supplemented, would not have a significant impact on the quality of the human environment.  A new Decision/FONSI for the EA, as supplemented, was signed July 17, 2013.

Public Noticed Until September 9, 2013

Interested parties may obtain a copy of the Decision/FONSI by clicking the following link:

2013 Decision/FONSI for the Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia

Or by contacting:


Staff Wildlife Biologist
USDA APHIS Wildlife Services
140-C Locust Grove Road
Pittstown, NJ 08867
Phone: (908) 735-5654
Fax: (908) 735-0821

Interested parties may also obtain copies of the EA, the 2012 Decision/FONSI, and the supplement to the EA by sending a request to the address above or by clicking on the following links:

2012 Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia

2012 Decision/FONSI for the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia

2013 Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia

 

 

 

 

 

 

 

 

Last Modified: July 31, 2013